Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Ambuja Cement Foundation Noncommunicable Disease Program in Bathinda District of Punjab, India

NCT04827615 is registered in ClinicalTrials.gov with Harvard School of Public Health (HSPH) as lead sponsor.

NCT NCT04827615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04827615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Ambuja Cement Foundation Noncommunicable Disease Program in Bathinda District of Punjab, India
Lead sponsor
Harvard School of Public Health (HSPH)
Phase
Not applicable
Overall status
Completed
Start date
July 30, 2019
Completion date
September 30, 2024
Enrollment
11,322 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

behavior, health, blood glucose, high, blood glucose, low, blood pressure, body weight, diabetes type 2, lifestyle-related condition, non communicable diseases